ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026
Zinzino group revenue increased 18 % in Q3, compared with the previous year.
The revenue in September for Zinzino's sales markets increased by 15% and amounted to SEK 310.9 (270.8) million. Faun Pharma's external sales increased and amounted to SEK 6.4 (3.7) million. Overall, the Group increased revenues by 16% to SEK 317.3 (274.5) million compared with the previous year.
Revenue in Zinzino's sales markets increased by 18% in the third quarter of 2026 compared with the same period last year and amounted to SEK 917.3 (774.8) million. Total revenues in the Group increased by 18% in the third quarter and amounted to SEK 928.2 (784.1) million.
Accumulated revenue for January – September 2026 increased by 21% to SEK 2,787.1 (2,302.2) million.
Revenues were distributed as follows:
| Regions, mSEK | 26-Sep | 25-Sep | Change | Q3 2026 | Q3 2025 | Change | YTD 2026 | YTD 2025 | Change |
| The Nordics | 26.6 | 25.5 | 5% | 76.1 | 78.7 | -3% | 233.8 | 234.1 | 0% |
| Central Europe | 102.9 | 93.4 | 10% | 288.8 | 242.4 | 19% | 846.5 | 657.5 | 29% |
| East Europe | 25.5 | 29.3 | -13% | 76.7 | 89.6 | -14% | 243.0 | 276.0 | -12% |
| South & West Europe | 48.9 | 48.9 | 0% | 144.1 | 136.0 | 6% | 451.4 | 398.0 | 13% |
| The Baltics | 8.2 | 8.8 | -7% | 24.8 | 28.5 | -13% | 81.3 | 85.2 | -5% |
| North America | 62.2 | 39.8 | 56% | 195. | 126.1 | 55% | 596.4 | 373.7 | 60% |
| South America | 3.6 | 1.3 | 177% | 10.1 | 3.5 | 189% | 32.8 | 8.2 | 300% |
| Asia-Pacific | 30.9 | 22.0 | 40% | 95.1 | 64.2 | 48% | 237.2 | 213.2 | 11% |
| Africa | 2.1 | 1.9 | 11% | 6.5 | 5.8 | 12% | 18.8 | 16.0 | 18% |
| Zinzino | 310.9 | 270.8 | 15% | 917.3 | 774.8 | 18% | 2,741.2 | 2,261.9 | 21% |
| Faun Pharma | 6.4 | 3.7 | 73% | 10.9 | 9.3 | 17% | 45.9 | 40.3 | 14% |
| Zinzino Group | 317.3 | 274.5 | 16% | 928.2 | 784.1 | 18% | 2,787.1 | 2,302.2 | 21% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ)
Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company's test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino's headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.
https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-q3-2026%2Cc4404120